Does anyone remember how people thought that INNV would have a trading halt, if/when Fluticare received FDA OTC approval? What a joke that was, GSK didn't have a trading halt after Flonase, nor did Bayer or Perrigo, or Costco.
Some of the wind has been taken out of this Fluticare sales work around, because it contains a middle man (according to one of the articles.)
Since the INNV share price hasn't moved up with this Fluticare announcement, maybe it won't move up at all, even after or if/when the original ANDA is approved?
It appears to me that the FDA is intentionally dragging their feet on the original ANDA Fluticare approval, due to corruption and GSK and Bayer probably paying them bribes under the table, to squash INNV.
It's amazing how the Fluticare hype approval boosted the share price up in the past, but now since it was already talked about so many times, it's like crying wolf and now it doesn't seem to matter much anymore.
From here on out, the main way to get the PPS up now is probably through sales, not through hype.
Please, no more dilution or crazy reverse splits.
